Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Asunercept by Apogenix for Solid Tumor: Likelihood of Approval
Asunercept is under clinical development by Apogenix and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
Data Insights
Asunercept by Apogenix for Hematological Tumor: Likelihood of Approval
Asunercept is under clinical development by Apogenix and currently in Phase I for Hematological Tumor. According to GlobalData, Phase I...